Bracco Imaging, NYU Langone Alliance
Analysis based on 6 articles · First reported Apr 20, 2026 · Last updated Apr 23, 2026
The strategic alliance between Bracco S.p.A. — Bracco Imaging and NYU Langone Health is expected to positively impact the medical imaging market by accelerating innovation in diagnostic technologies. This collaboration could lead to advancements in precision medicine, benefiting patients and healthcare systems globally.
Bracco S.p.A. — Bracco Imaging and NYU Langone Health announced a strategic alliance through a multi-year Master Research Agreement (MRA) on April 20, 2026. This collaboration aims to advance innovation in medical imaging, focusing on areas such as MRI, PCCT, targeted ultrasound, and AI-enabled PET/CT and MRI image analysis. The partnership combines the resources, scientific capabilities, and expertise of both entities to accelerate the development and optimization of advanced imaging technologies, enhance clinical insights, and improve patient management. Fulvio Renoldi Bracco, CEO of Bracco S.p.A. — Bracco Imaging, and Michael P. Recht, chair of the Department of Radiology at NYU Grossman School of Medicine, both emphasized the shared commitment to research and clinical innovation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard